Apnimed, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | +446.5% | +395.7% | -85.8% | |
| – | +30.9% | +25.3% | -44.0% | |
| – | +748.2% | +437.2% | -86.8% | |
| – | -31.9% | -49.3% | +22.2% | |
| – | -2.1% | +21.5% | +94.8% | |
| – | -23.8% | -27.2% | +41.8% | |
| – | – | – | -117.2% | |
| – | – | – | +79.2% | |
| – | – | – | +79.0% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.